MediciNova, Inc. (MNOV)
1.52
-0.02
(-1.30%)
USD |
NASDAQ |
Oct 09, 16:00
1.35
-0.17
(-11.18%)
After-Hours: 06:05
MediciNova Free Cash Flow (Quarterly) : -1.92M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.92M |
| March 31, 2026 | -3.481M |
| December 31, 2025 | -2.017M |
| September 30, 2025 | -1.706M |
| June 30, 2025 | -2.306M |
| March 31, 2025 | -3.784M |
| December 31, 2024 | -1.932M |
| September 30, 2024 | -2.032M |
| June 30, 2024 | -2.812M |
| March 31, 2024 | -3.868M |
| December 31, 2023 | -0.4991M |
| September 30, 2023 | -1.374M |
| June 30, 2023 | -2.402M |
| March 31, 2023 | -3.177M |
| December 31, 2022 | -4.012M |
| September 30, 2022 | -2.720M |
| June 30, 2022 | -2.456M |
| March 31, 2022 | -3.728M |
| December 31, 2021 | -3.639M |
| September 30, 2021 | -3.018M |
| June 30, 2021 | 1.101M |
| March 31, 2021 | -3.854M |
| December 31, 2020 | -1.982M |
| September 30, 2020 | -3.909M |
| June 30, 2020 | -2.091M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.881M |
| December 31, 2019 | -2.412M |
| September 30, 2019 | -2.039M |
| June 30, 2019 | -1.654M |
| March 31, 2019 | -3.031M |
| December 31, 2018 | -1.644M |
| September 30, 2018 | -1.736M |
| June 30, 2018 | -1.655M |
| March 31, 2018 | -4.09M |
| December 31, 2017 | -1.046M |
| September 30, 2017 | -1.919M |
| June 30, 2017 | -1.411M |
| March 31, 2017 | -2.547M |
| December 31, 2016 | -1.076M |
| September 30, 2016 | -1.616M |
| June 30, 2016 | -1.497M |
| March 31, 2016 | -2.441M |
| December 31, 2015 | -1.517M |
| September 30, 2015 | -1.172M |
| June 30, 2015 | -1.233M |
| March 31, 2015 | -3.234M |
| December 31, 2014 | -1.033M |
| September 30, 2014 | -1.591M |
| June 30, 2014 | -1.328M |
| March 31, 2014 | 4.765M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Viking Therapeutics, Inc. | -125.17M |
| IDEAYA Biosciences, Inc. | -89.08M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Alnylam Pharmaceuticals, Inc. | 292.04M |